Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Epithelial Pleural Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00027703
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 106
Testing effectiveness (Phase 2)Study completedNCT00484276
What this trial is testing

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 57
Early research (Phase 1)Study completedNCT00652574
What this trial is testing

Dasatinib in Resectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
M.D. Anderson Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT02347917
What this trial is testing

BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaNon-Small Cell Lung Cancer
Sumitomo Pharma Co., Ltd. 28
Testing effectiveness (Phase 2)Ended earlyNCT00027508
What this trial is testing

Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
PharmaMar
Not applicableStudy completedNCT03068117
What this trial is testing

Malignant Mesothelioma - Can we Improve Quality of Life

Who this might be right for
Mesothelioma, Malignant
Portsmouth Hospitals NHS Trust 319
Large-scale testing (Phase 3)Study completedNCT00190762
What this trial is testing

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Who this might be right for
Mesothelioma
Eli Lilly and Company 240
Testing effectiveness (Phase 2)Study completedNCT00017186
What this trial is testing

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 69
Large-scale testing (Phase 3)Study completedNCT00821860
What this trial is testing

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
Papworth Hospital NHS Foundation Trust 196
Testing effectiveness (Phase 2)WithdrawnNCT06654050
What this trial is testing

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

Who this might be right for
MesotheliomaMalignant Mesothelioma (MM)Early-stage Mesothelioma+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00458913
What this trial is testing

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 82
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)UnknownNCT01279967
What this trial is testing

A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Barts & The London NHS Trust 70
Not applicableUnknownNCT01912547
What this trial is testing

Thromboelastography During Surgery for Malignant Pleural Mesothelioma

Who this might be right for
CoagulopathyMesothelioma
Brigham and Women's Hospital 100
Large-scale testing (Phase 3)Study completedNCT00075699
What this trial is testing

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Medical Research Council 840
Testing effectiveness (Phase 2)Study completedNCT03399552
What this trial is testing

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma (MPM)
Memorial Sloan Kettering Cancer Center 15
Early research (Phase 1)Study completedNCT04153565
What this trial is testing

Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)

Who this might be right for
Mesothelioma
Merck Sharp & Dohme LLC 19
Testing effectiveness (Phase 2)Study completedNCT02568449
What this trial is testing

Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent

Who this might be right for
Recurrent Pleural Malignant MesotheliomaStage IV Pleural Mesothelioma
Barbara Ann Karmanos Cancer Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT01105390
What this trial is testing

AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00101283
What this trial is testing

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Eastern Cooperative Oncology Group 32
Next Page